Ozempic, a diabetes drug commonly prescribed off-label for weight loss, has recently been linked to serious side effects such as gastroparesis (stomach paralysis), intestinal blockages, and severe gastrointestinal distress. As reports of long-term complications continue to rise, patients across the country are filing lawsuits against the manufacturer, Novo Nordisk, for failing to adequately warn about the risks.